Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery

Conclusion: Since clotting is faster in the new S2 compared to S1, shorter clotting times have to be considered in clinical practice. The use of S2 kACT in heparin management will result in higher heparin and protamine dosing unless heparin kACT target values are adjusted to correct for the differences in results between S1 and S2.

http://cat.sagepub.com/cgi/content/abstract/23/1/20?rss=1

Source: Clinical and Applied Thrombosis/Hemostasis - November 27, 2016 Category: Hematology Authors: Dzemali, O., Ganter, M. T., Zientara, A., Graves, K., Behr, R., Genoni, M., Hofer, C. K. Tags: Original Articles Source Type: research